Skip to main content

Derma µBiomic

Skin Restoring Probiotic

A skin-nourishing probiotic containing Alimentum Labs’ patent-pending blend of unique probiotics that regulate immune function and promote healthy skin by supporting the gut-skin axis.

  • Skin

    Skin

  • Whole Body

    Whole Body

  • Immunity

    Immunity

Health Indications

  • Regulates Autoimmune Reactions
  • Resolves Persistent and Recurrent Pathogen Growth
  • Supports a Diverse Gut and Skin Microbiome
  • Reduces Inflammation
  • Boosts Natural Skin Repair Mechanisms

Instructions For Use

Take 1-2 capsules daily for 30 days with or without food. Refrigerate after opening to optimize shelf life.

We recommend Derma μBiomic be paired with its synergistic topical formula, Derma Serum, for unparalleled results and remarkable skin health benefits.

**Individual needs may vary; please consult your practitioner before altering the prescribed doses or protocols.

Product Description

Derma µBiomic - Product Description

In the midst of modern lifestyle challenges and environmental pollution, our skin faces constant stress. Derma μBiomic is crafted to address these concerns and enhance skin health by leveraging the intricate gut-skin axis.

In today’s world, where pollutants and daily stresses take a toll on our skin, this skin restoring probiotic offers a gentle, yet powerful approach. The gut-skin axis, a sophisticated system connecting the gastrointestinal microbiome and immune system to the skin, plays a pivotal role in skin health. Derma μBiomic acts as a bridge between inner and outer health, nourishing your gut microbiota and fortifying your skin’s immune system.

Derma µBiomic - Product Description

Ongoing research on skin microbiota highlights a clear link between microbial diversity and the resilience of our skin’s immune defenses. The surprising, yet intricate connection between the gastrointestinal immune system, gut microbiota, and skin health behavior, underscores the importance of this distant relationship – the gut-skin axis.

Derma μBiomic supplements specific probiotics that provide a myriad of benefits for your skin. Experience improvements in skin appearance as these probiotics work in harmony with your gut and skin’s immune cells. Our product is designed not only to enhance skin aesthetics but also to bolster overall immune function in the skin.

In the face of skin conditions exacerbated by our modern lifestyle, Derma μBiomic is your ally, offering a proactive solution. Elevate your skincare routine with the science-backed benefits of Derma μBiomic and embrace healthier, more resilient, and radiant skin that withstands the challenges of contemporary living.

Key Elements and Features of Derma µBiomic

  • Autoimmune Skin Support

    Consumption of Derma μBiomic’s unique combination of probiotics partners with the body’s immune system to manage and alleviate symptoms of autoimmune-related skin conditions.

  • Fights Acne

    Reduces and manages acne by inhibiting the growth of pathogenic skin microbes, promoting the growth of a thriving skin microbiome, and curbing inflammation.

  • Supports A Healthy Skin Barrier

    By using intrinsic pathways in the body, Derma μBiomic boosts hydration, supports cellular collagen and hyaluronic acid production, balances skin pH, and mitigates UV damage for visibly improved skin health.

  • Develops and Manages a Healthy Microbiome

    Promotes a diverse and balanced microbiome throughout the whole body by starting in the gut; this helps repair the gut-skin axis for long-term benefits.

Exclusive Probiotic Spotlight

It may seem surprising that consuming probiotics can improve and nourish skin, however consumable probiotics target skin health in a unique way. While topical probiotics can be hugely beneficial by providing surface-level benefits, consumable probiotics work to repair, revitalize, and maintain skin health from the inside out, thanks to the underappreciated gut-skin axis.

Derma μBiomic is specifically formulated to include probiotic strains known to modulate the gut microbiome, interact with the immune system, and have demonstrated healing effects on the skin in clinical trials. These strains of probiotics reduce inflammation, promote healing, revitalize the skin, and inhibit pathogen growth in the gut and on the skin.

How Derma µBiomic Works

Years of scientific research have gone into the development of Derma μBiomic to create a product that supports and repairs problematic skin through the gut-skin axis. Through oral consumption, Derma μBiomic enables the probiotics to interact with immune cells in the gastrointestinal tract. These interactions educate and prime the immune system, allowing the immune system to respond appropriately to external invaders without overreacting to normal inhabitants and contact. When the immune system functions properly, the innate mechanics of skin repair, function, and health can reach their full potential.

How It Works

Key Ingredients

Bacillus licheniformis BL-GA26

B. licheniformis produces exopolysaccharides (EPSs) that have shown immunoregulatory, antimicrobial, antiviral, and antiparasitic effects.1 Most notably, it produces an antibacterial substance known as bacitracin, which is the active ingredient in the topical ointment used for minor skin injuries, named after this protective compound.2

Propionibacterium freudenreichii

P. freudenreichii is an important dairy fermenting strain, primarily in cheeses, where it contributes to the formation of the characteristic “eyes” in swiss cheese by producing carbon dioxide.3 It also produces numerous beneficial postbiotics, including propionic and acetic acid, B vitamins, all essential amino acids, and DHNA which increases the growth of beneficial Bifidobacteria and is a vitamin K2 intermediate.3–5 Studies have reported its ability to reduce the risk of eczema in infants.6

Lacticaseibacillus rhamnosus GG

L. rhamnosus was shown to effectively treat atopic dermatitis and improve quality of life in a double-blind, clinical trial.7 It has also demonstrated its ability to prevent infection of human skin cells by Staphylococcus aureus by enhancing the body’s natural immune response and adjusting pH.8

Bifidobacterium lactis SD-5859

B. lactis, also known as Bifidobacterium animalis ssp. lactis, was originally isolated from commercial dairy products and is now widely manufactured as a probiotic that produces beneficial lactic acid and acetate.9,10 When given in combination with prebiotics, it has the potential to reduce inflammation and increase levels of bifidobacterium in the gut.11 When given in combination with other probiotics to high risk infants, there was a 40% reduction in inflammatory factors and atopic dermatitis development.12

Bifidobacterium bifidum SD-6576

B. bifidum feeds primarily on sugars found in human breast milk, which allow it to colonize the intestine immediately after birth. Since it also has the ability to break down the mucin lining the intestine, it can persist in the gut into adulthood, albeit at lower levels.13,14 This probiotic strain produces beneficial postbiotics, including lactic acid, acetate, and vitamin B1.13,15,16 Studies have demonstrated its effectiveness in reducing skin inflammation associated with eczema, as well as reducing the occurrence of eczema in infants when given to pregnant mothers and then to newborn infants.17–20 Additionally, it has been found to eliminate symptoms related to milk allergy in infants.21

Ligilactobacillus salivarius SD-5851

In a clinical trial, L. salivarius was shown to reduce acne lesions and inflammation. Additionally, it decreased the populations of bacteria that were pathogenic to the skin.22

Limosilactobacillus fermentum

L. fermentum produces lactic acid, acetic acid, cyclic dipeptides, and exopolysaccharides, all which play a role in its ability to inhibit pathogens like Candida and Staphylococcus aureus.23–27 It also produces nicotinamide, which helps reduce oxidative damage in cells exposed to UV light.28 L. fermentum has been found to inhibit melanin production, thereby addressing skin conditions and cancer risks associated with its overproduction.29 Additionally, it enhances skin hydration by increasing the production of hyaluronic acid, thereby improving its ability to protect the skin against damage and infection.27 Furthermore, L. fermentum supports skin health through educating the immune system and regulating normal inflammatory responses.30

Lacticaseibacillus paracasei 134134

L. paracasei has been shown to regulate the immune system after oral consumption, allowing it to support skin health from the inside out. In addition to inhibiting pathogen growth, it can also help prevent dryness and inflammation of the scalp.31

Lacticaseibacillus casei SD-5842

L. casei supports skin health through the gut-skin axis by reducing overall inflammation and flakiness. Protecting the skin barrier in this way also helps prevent issues such as infection, scarring, itchiness, and more.32

Micrococcus luteus

M. luteus produces a carotenoid pigment that filters long-wave UV radiation.33 Long wave UV filtering is a feature rarely included in sunscreen products. Therefore M. luteus has been included in proposals to produce sunscreens containing this pigment to enhance skin protection.34 Studies indicate that this probiotic has the potential to improve visual characteristics of the skin, as well as reduce the number of potentially pathogenic bacteria.33

Lactococcus lactis SD-5848

L. lactis, also known as Lactococcus lactis ssp lactis, produces exopolysaccharides (EPSs), which have known immunomodulatory effects.39 When taken orally, it has been shown to decrease pathogenic Staphylococcus aureus colonization on the skin.40 Topical application has also been reported to improve skin hydration and enhance its ability to provide protection.41 Additionally, when combined with yellow LED light therapy, it synergistically healed burn wounds.42 Oral supplementation of L. lactis has also shown efficiency in improving eczema symptoms.43

Warnings/Contraindications

When used as directed there are no known contraindications for Derma µBiomic.

**It is always recommended that you consult your practitioner prior to adding any new supplement to your regimen if you are pregnant, breastfeeding, experiencing renal failure, undergoing an organ transplant(s), managing diabetes with insulin, or are taking medication(s) for any pre-existing conditions.**

Safety

All ingredients are tested before use for:

  • Pathogenic microbial contaminants
  • Heavy metals and/or chemical contaminants
  • Correct genus and species of probiotic microbes
  • Purity

Additional Information

  • Gluten Free
  • Dairy Free
  • Vegan
  • No Sugar
  • Non-GMO
  • cGMP Facility
  • No Egg

References

  1. Muras, A.; Romero, M.; Mayer, C.; Otero, A. Biotechnological Applications of Bacillus Licheniformis. Crit. Rev. Biotechnol. 2021, 41 (4), 609–627. https://doi.org/10.1080/07388551.2021.1873239.
  2. Nguyen, R.; Khanna, N. R.; Safadi, A. O.; Sun, Y. Bacitracin Topical. In StatPearls; StatPearls Publishing: Treasure Island (FL), 2024.
  3. Falentin, H.; Deutsch, S.-M.; Jan, G.; Loux, V.; Thierry, A.; Parayre, S.; Maillard, M.-B.; Dherbécourt, J.; Cousin, F. J.; Jardin, J.; Siguier, P.; Couloux, A.; Barbe, V.; Vacherie, B.; Wincker, P.; Gibrat, J.-F.; Gaillardin, C.; Lortal, S. The Complete Genome of Propionibacterium Freudenreichii CIRM-BIA1T, a Hardy Actinobacterium with Food and Probiotic Applications. PLOS ONE 2010, 5 (7), e11748. https://doi.org/10.1371/journal.pone.0011748.
  4. Thierry, A.; Deutsch, S.-M.; Falentin, H.; Dalmasso, M.; Cousin, F. J.; Jan, G. New Insights into Physiology and Metabolism of Propionibacterium Freudenreichii. Int. J. Food Microbiol. 2011, 149 (1), 19–27. https://doi.org/10.1016/j.ijfoodmicro.2011.04.026.
  5. Yeom, J.; Ma, S.; Lim, Y.-H. Probiotic Propionibacterium Freudenreichii MJ2 Enhances Osteoblast Differentiation and Mineralization by Increasing the OPG/RANKL Ratio. Microorganisms 2021, 9 (4), 673. https://doi.org/10.3390/microorganisms9040673.
  6. Amalia, N.; Orchard, D.; Francis, K. L.; King, E. Systematic Review and Meta-Analysis on the Use of Probiotic Supplementation in Pregnant Mother, Breastfeeding Mother and Infant for the Prevention of Atopic Dermatitis in Children. Australas. J. Dermatol. 2020, 61 (2), e158–e173. https://doi.org/10.1111/ajd.13186.
  7. Carucci, L.; Nocerino, R.; Paparo, L.; De Filippis, F.; Coppola, S.; Giglio, V.; Cozzolino, T.; Valentino, V.; Sequino, G.; Bedogni, G.; Russo, R.; Ercolini, D.; Berni Canani, R. Therapeutic Effects Elicited by the Probiotic Lacticaseibacillus Rhamnosus GG in Children with Atopic Dermatitis. The Results of the ProPAD Trial. Pediatr. Allergy Immunol. 2022, 33 (8), e13836. https://doi.org/10.1111/pai.13836.
  8. Spacova, I.; O’Neill, C.; Lebeer, S. Lacticaseibacillus Rhamnosus GG Inhibits Infection of Human Keratinocytes by Staphylococcus Aureus through Mechanisms Involving Cell Surface Molecules and pH Reduction. Benef. Microbes 2020, 11 (7), 703–715. https://doi.org/10.3920/BM2020.0075.
  9. Jungersen, M.; Wind, A.; Johansen, E.; Christensen, J. E.; Stuer-Lauridsen, B.; Eskesen, D. The Science behind the Probiotic Strain Bifidobacterium Animalis Subsp. Lactis BB-12®. Microorganisms 2014, 2 (2), 92–110. https://doi.org/10.3390/microorganisms2020092.
  10. Cheng, J.; Laitila, A.; Ouwehand, A. C. Bifidobacterium Animalis Subsp. Lactis HN019 Effects on Gut Health: A Review. Front. Nutr. 2021, 8.
  11. Childs, C. E.; Röytiö, H.; Alhoniemi, E.; Fekete, A. A.; Forssten, S. D.; Hudjec, N.; Lim, Y. N.; Steger, C. J.; Yaqoob, P.; Tuohy, K. M.; Rastall, R. A.; Ouwehand, A. C.; Gibson, G. R. Xylo-Oligosaccharides Alone or in Synbiotic Combination with Bifidobacterium Animalis Subsp. Lactis Induce Bifidogenesis and Modulate Markers of Immune Function in Healthy Adults: A Double-Blind, Placebo-Controlled, Randomised, Factorial Cross-over Study. Br. J. Nutr. 2014, 111 (11), 1945–1956. https://doi.org/10.1017/S0007114513004261.
  12. Lolou, V.; Panayiotidis, M. I. Functional Role of Probiotics and Prebiotics on Skin Health and Disease. Fermentation 2019, 5 (2), 41. https://doi.org/10.3390/fermentation5020041.
  13. Milani, C.; Duranti, S.; Bottacini, F.; Casey, E.; Turroni, F.; Mahony, J.; Belzer, C.; Delgado Palacio, S.; Arboleya Montes, S.; Mancabelli, L.; Lugli, G. A.; Rodriguez, J. M.; Bode, L.; de Vos, W.; Gueimonde, M.; Margolles, A.; van Sinderen, D.; Ventura, M. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol. Mol. Biol. Rev. MMBR 2017, 81 (4), e00036-17. https://doi.org/10.1128/MMBR.00036-17.
  14. Bottacini, F.; van Sinderen, D.; Ventura, M. Omics of Bifidobacteria: Research and Insights into Their Health-Promoting Activities. Biochem. J. 2017, 474 (24), 4137–4152. https://doi.org/10.1042/BCJ20160756.
  15. Bahmani, S.; Azarpira, N.; Moazamian, E. Anti-Colon Cancer Activity of Bifidobacterium Metabolites on Colon Cancer Cell Line SW742. Turk. J. Gastroenterol. 2019, 30 (9), 835–842. https://doi.org/10.5152/tjg.2019.18451.
  16. Yoshii, K.; Hosomi, K.; Sawane, K.; Kunisawa, J. Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity. Front. Nutr. 2019, 6.
  17. Holowacz, S.; Blondeau, C.; Guinobert, I.; Guilbot, A.; Hidalgo, S.; Bisson, J. F. Lactobacillus Salivarius LA307 and Lactobacillus Rhamnosus LA305 Attenuate Skin Inflammation in Mice. Benef. Microbes 2018, 9 (2), 299–309. https://doi.org/10.3920/BM2017.0084.
  18. Roudsari, M. R.; Karimi, R.; Sohrabvandi, S.; Mortazavian, A. M. Health Effects of Probiotics on the Skin. Crit. Rev. Food Sci. Nutr. 2015, 55 (9), 1219–1240. https://doi.org/10.1080/10408398.2012.680078.
  19. Kim, J. Y.; Kwon, J. H.; Ahn, S. H.; Lee, S. I.; Han, Y. S.; Choi, Y. O.; Lee, S. Y.; Ahn, K. M.; Ji, G. E. Effect of Probiotic Mix (Bifidobacterium Bifidum, Bifidobacterium Lactis, Lactobacillus Acidophilus) in the Primary Prevention of Eczema: A Double-Blind, Randomized, Placebo-Controlled Trial. Pediatr. Allergy Immunol. Off. Publ. Eur. Soc. Pediatr. Allergy Immunol. 2010, 21 (2 Pt 2), e386-393. https://doi.org/10.1111/j.1399-3038.2009.00958.x.
  20. Dolan, K. E.; Pizano, J. M.; Gossard, C. M.; Williamson, C. B.; Burns, C. M.; Gasta, M. G.; Finley, H. J.; Parker, E. C.; Lipski, E. A. Probiotics and Disease: A Comprehensive Summary—Part 6, Skin Health. Integr. Med. Clin. J. 2017, 16 (4), 32–41.
  21. Jing, W.; Liu, Q.; Wang, W. Bifidobacterium Bifidum TMC3115 Ameliorates Milk Protein Allergy in by Affecting Gut Microbiota: A Randomized Double-Blind Control Trial. J. Food Biochem. 2020, 44 (11), e13489. https://doi.org/10.1111/jfbc.13489.
  22. Rinaldi, F.; Marotta, L.; Mascolo, A.; Amoruso, A.; Pane, M.; Giuliani, G.; Pinto, D. Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement. Dermatol. Ther. 2022, 12 (2), 577–589. https://doi.org/10.1007/s13555-021-00664-z.
  23. Rodríguez-Sojo, M. J.; Ruiz-Malagón, A. J.; Rodríguez-Cabezas, M. E.; Gálvez, J.; Rodríguez-Nogales, A. Limosilactobacillus Fermentum CECT5716: Mechanisms and Therapeutic Insights. Nutrients 2021, 13 (3), 1016. https://doi.org/10.3390/nu13031016.
  24. Kawai, T.; Ohshima, T.; Tanaka, T.; Ikawa, S.; Tani, A.; Inazumi, N.; Shin, R.; Itoh, Y.; Meyer, K.; Maeda, N. Limosilactobacillus (Lactobacillus) Fermentum ALAL020, a Probiotic Candidate Bacterium, Produces a Cyclic Dipeptide That Suppresses the Periodontal Pathogens Porphyromonas Gingivalis and Prevotella Intermedia. Front. Cell. Infect. Microbiol. 2022, 12, 804334. https://doi.org/10.3389/fcimb.2022.804334.
  25. Pakroo, S.; Tarrah, A.; Takur, R.; Wu, M.; Corich, V.; Giacomini, A. Limosilactobacillus Fermentum ING8, a Potential Multifunctional Non-Starter Strain with Relevant Technological Properties and Antimicrobial Activity. Foods 2022, 11 (5), 703. https://doi.org/10.3390/foods11050703.
  26. dos Santos, C. I.; Campos, C. D. L.; Nunes-Neto, W. R.; do Carmo, M. S.; Nogueira, F. A. B.; Ferreira, R. M.; Costa, E. P. S.; Gonzaga, L. F.; Araújo, J. M. M.; Monteiro, J. M.; Monteiro, C. R. A. V.; Platner, F. S.; Figueiredo, I. F. S.; Holanda, R. A.; Monteiro, S. G.; Fernandes, E. S.; Monteiro, A. S.; Monteiro-Neto, V. Genomic Analysis of Limosilactobacillus Fermentum ATCC 23271, a Potential Probiotic Strain with Anti-Candida Activity. J. Fungi 2021, 7 (10), 794. https://doi.org/10.3390/jof7100794.
  27. Lee, J. Y.; Kim, Y.; Kim, J.-I.; Lee, H.-Y.; Moon, G.-S.; Kang, C.-H. Improvements in Human Keratinocytes and Antimicrobial Effect Mediated by Cell-Free Supernatants Derived from Probiotics. Fermentation 2022, 8 (7), 332. https://doi.org/10.3390/fermentation8070332.
  28. Chen, H.; Li, Y.; Xie, X.; Chen, M.; Xue, L.; Wang, J.; Ye, Q.; Wu, S.; Yang, R.; Zhao, H.; Zhang, J.; Ding, Y.; Wu, Q. Exploration of the Molecular Mechanisms Underlying the Anti-Photoaging Effect of Limosilactobacillus Fermentum XJC60. Front. Cell. Infect. Microbiol. 2022, 12, 838060. https://doi.org/10.3389/fcimb.2022.838060.
  29. Meng, Z.; Oh, S. Antioxidant and Antimelanogenic Activities of Kimchi-Derived Limosilactobacillus Fermentum JNU532 in B16F10 Melanoma Cells. 2021, 31 (7), 990–998. https://doi.org/10.4014/jmb.2104.04008.
  30. Chen, H.; Li, Y.; Xie, X.; Chen, M.; Xue, L.; Wang, J.; Ye, Q.; Wu, S.; Yang, R.; Zhao, H.; Zhang, J.; Ding, Y.; Wu, Q. Exploration of the Molecular Mechanisms Underlying the Anti-Photoaging Effect of Limosilactobacillus Fermentum XJC60. Front. Cell. Infect. Microbiol. 2022, 12, 838060. https://doi.org/10.3389/fcimb.2022.838060.
  31. Gao, T.; Wang, X.; Li, Y.; Ren, F. The Role of Probiotics in Skin Health and Related Gut–Skin Axis: A Review. Nutrients 2023, 15 (14), 3123. https://doi.org/10.3390/nu15143123.
  32. Yang, J.; Cho, H.; Gil, M.; Kim, K. E. Anti-Inflammation and Anti-Melanogenic Effects of Maca Root Extracts Fermented Using Lactobacillus Strains. Antioxidants 2023, 12 (4), 798. https://doi.org/10.3390/antiox12040798.
  33. Jain, R.; Voss, A. L.; Tagg, J. R.; Hale, J. D. F. Evaluation of the Preliminary Safety, Tolerability and Colonisation Efficacy of Topical Probiotic Formulations Containing Micrococcus Luteus Q24 in Healthy Human Adults. Cosmetics 2022, 9 (6), 121. https://doi.org/10.3390/cosmetics9060121.
  34. Super sunscreen from fjord bacteria. ScienceDaily. https://www.sciencedaily.com/releases/2013/08/130806091556.htm (accessed 2024-02-05).
  35. Chen, Y.; Li, N.; Zhao, S.; Zhang, C.; Qiao, N.; Duan, H.; Xiao, Y.; Yan, B.; Zhao, J.; Tian, F.; Zhai, Q.; Yu, L.; Chen, W. Integrated Phenotypic–Genotypic Analysis of Latilactobacillus Sakei from Different Niches. Foods 2021, 10 (8), 1717. https://doi.org/10.3390/foods10081717.
  36. Rather, I. A.; Bajpai, V. K.; Huh, Y. S.; Han, Y.-K.; Bhat, E. A.; Lim, J.; Paek, W. K.; Park, Y.-H. Probiotic Lactobacillus Sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model. Front. Microbiol. 2018, 9.
  37. Park, J.-Y.; Lee, J. Y.; Kim, Y.; Kang, C.-H. Latilactobacillus Sakei Wikim0066 Protects Skin through MMP Regulation on UVB-Irradiated In Vitro and In Vivo Model. Nutrients 2023, 15 (3), 726. https://doi.org/10.3390/nu15030726.
  38. Kwon, M.-S.; Lim, S. K.; Jang, J.-Y.; Lee, J.; Park, H. K.; Kim, N.; Yun, M.; Shin, M.-Y.; Jo, H. E.; Oh, Y. J.; Roh, S. W.; Choi, H.-J. Lactobacillus Sakei WIKIM30 Ameliorates Atopic Dermatitis-Like Skin Lesions by Inducing Regulatory T Cells and Altering Gut Microbiota Structure in Mice. Front. Immunol. 2018, 9.
  39. Casalta, E.; Montel, M.-C. Safety Assessment of Dairy Microorganisms: The Lactococcus Genus. Int. J. Food Microbiol. 2008, 126 (3), 271–273. https://doi.org/10.1016/j.ijfoodmicro.2007.08.013.
  40. Fujii, T.; Fujitomo, T.; Tsuji, R.; Kubo, R.; Kato, Y.; Kanauchi, O. Effects of Heat-Killed Lactococcus Lactis Strain Plasma on Skin Homeostasis-Related Genes and the Skin Microbiome among Healthy Adults: A Randomized Controlled Double-Blind Study. Microorganisms 2021, 9 (10), 2029. https://doi.org/10.3390/microorganisms9102029.
  41. Hausmann, C.; Hertz-Kleptow, D.; Zoschke, C.; Wanjiku, B.; Wentzien-Odenthal, A.; Kerscher, M.; Schäfer-Korting, M. Reconstructed Human Epidermis Predicts Barrier-Improving Effects of Lactococcus Lactis Emulsion in Humans. Skin Pharmacol. Physiol. 2019, 32 (2), 72–80. https://doi.org/10.1159/000495255.
  42. Zhao, X.; Li, S.; Ding, J.; Wei, J.; Tian, P.; Wei, H.; Chen, T. Combination of an Engineered Lactococcus Lactis Expressing CXCL12 with Light-Emitting Diode Yellow Light as a Treatment for Scalded Skin in Mice. Microb. Biotechnol. 2021, 14 (5), 2090–2100. https://doi.org/10.1111/1751-7915.13885.
  43. Suzuki, T.; Nishiyama, K.; Kawata, K.; Sugimoto, K.; Isome, M.; Suzuki, S.; Nozawa, R.; Ichikawa, Y.; Watanabe, Y.; Suzutani, T. Effect of the Lactococcus Lactis 11/19-B1 Strain on Atopic Dermatitis in a Clinical Test and Mouse Model. Nutrients 2020, 12 (3), 763. https://doi.org/10.3390/nu12030763.
← Back To White Paper Directory